Funding provided to develop new therapy for acute liver failure

9 Sep 2015, 4:50 p.m.

Dr Kevin Mills

BRC-supported researcher Dr Kevin Mills has been awarded funding from the NIHR to investigate the regenerative ability of the liver following acute liver failure (ALF). If successful, the team hope that their research will lead to a novel therapy that could buy patients enough time to allow their livers to regenerate naturally, avoiding the need for liver transplantsThis research will be led by Professor Anil Dhawan at Kings College London in collaboration with Dr Mills at UCL Institute of Child Health. Specifically, the team aim to develop a novel technique where human liver cells grown in the lab are encapsulated in a material called alginate and delivered to a patient to help their ailing liver regenerate. Encasing the liver cells in alginate is particularly important as it reduces the need for immunosuppression.

Studies in the lab will focus on the feasibility of this novel therapy under lab conditions.

What do bush babies, tamarin monkeys, and mouse lemurs have that humans don’t?

GOSH imaging researchers have worked with teams in Harvard in the USA to work out how and when our pelvises developed to be different from other animals.

Nanodiamonds and hormones used in rare condition to promote lung growth

An international research team led by GOSH, UCL and KU Leuven in Belgium, is using 3D-printing and nanodiamonds, to design treatments that could help babies repair their damaged lungs in the womb.

New national registry for inherited hearing loss

A new national registry is helping researchers understand more about inherited hearing loss – and could help bring about new treatments.

Teenager off to university after life-changing gene therapy

A teenager with a rare, life-limiting genetic condition is off to university after receiving a gene therapy that changed his life.